Ausgabe 1/2001
Inhalt (11 Artikel)
Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction
Stefan Ückert, Andrea Küthe, Christian G. Stief, Udo Jonas
Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications
A. Nehra, F. Colreavy, B. K. Khandheria, K. Chandrasekaran
Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials
D. Schultheiss, S. V. Müller, W. Nager, C. G. Stief, N. Schlote, U. Jonas, C. Asvestis, S. Johannes, T. F. Münte
Oral α adrenoceptor blockade as a treatment of erectile dysfunction
Karl-Erik Andersson, Christian Stief
Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study
T. Klotz, R. Sachse, A. Heidrich, F. Jockenhövel, G. Rohde, G. Wensing, R. Horstmann, R. Engelmann
Vasomax for the treatment of male erectile dysfunction
Irwin Goldstein, Culley Carson, Ray Rosen, Anita Islam